Bicycle Therapeutics (BCYC) Filings

S-8

Registration of securities for employees

25 Feb 25

8-K

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

25 Feb 25

8-K

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

13 Jan 25

8-K

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

13 Dec 24

8-K

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

31 Oct 24

8-K

Other Events

23 Oct 24

8-K

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

19 Sep 24

S-8

Registration of securities for employees

6 Aug 24

8-K

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

6 Aug 24

8-K

Termination of a Material Definitive Agreement

10 Jul 24

8-K

Other Events

18 Jun 24

424B7

Prospectus with selling stockholder info

18 Jun 24

D

$555.50 mm in equity, sold $555.50 mm, 19 investors

11 Jun 24

8-K

Entry into a Material Definitive Agreement

23 May 24

F-6EF

Automatic registration for ADRs (foreign)

16 May 24

8-K

Submission of Matters to a Vote of Security Holders

16 May 24

8-K

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

2 May 24

DEFA14A

Additional proxy soliciting materials

18 Apr 24

8-K

Entry into a Material Definitive Agreement

18 Apr 24

ARS

2023 FY

Annual report to shareholders

15 Apr 24

S-8

Registration of securities for employees

20 Feb 24

8-K

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

20 Feb 24

8-K

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

14 Dec 23

8-K

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

2 Nov 23

8-K

Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer

11 Sep 23

8-K

Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

3 Aug 23

8-K

Entry into a Material Definitive Agreement

13 Jul 23

424B5

Prospectus supplement for primary offering

13 Jul 23

424B5

Prospectus supplement for primary offering

12 Jul 23

8-K

Departure of Directors or Certain Officers

23 Jun 23

8-K

Submission of Matters to a Vote of Security Holders

14 Jun 23

SC 13G/A

Deep Track Capital, LP

14 Feb 25

SC 13G

WESTFIELD CAPITAL MANAGEMENT CO LP

11 Feb 25

4

Pierre Legault

6 Jan 25

4

Travis Alvin Thompson

6 Jan 25

4

Alethia Young

6 Jan 25

4

Santiago Arroyo

6 Jan 25

4

Nigel Crockett

6 Jan 25

4

Alistair Milnes

6 Jan 25

4

Michael Skynner

6 Jan 25

4

Michael Charles Ferguson Hannay

6 Jan 25

4

Kevin Lee

6 Jan 25

4

Gregory Paul Winter

6 Jan 25

4

Stephen H. Sands

6 Jan 25

4

Richard N Kender

6 Jan 25

4

Jose-Carlos Gutierrez-Ramos

6 Jan 25

4

Janice Bourque

6 Jan 25

4

JULIAN BAKER

6 Jan 25

144

Notice of proposed sale of securities

6 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

144

Notice of proposed sale of securities

2 Jan 25

SC 13G

Point72 Asset Management, L.P.

20 Dec 24

SC 13G

Forbion Growth Opportunities Fund II Cooperatief U.A.

19 Dec 24

SC 13D/A

BAKER BROS. ADVISORS LP

17 Dec 24

4

JULIAN BAKER

17 Dec 24

SC 13G/A

RA CAPITAL MANAGEMENT, L.P.

14 Nov 24

SC 13G/A

Paradigm Biocapital Advisors LP

14 Nov 24

SC 13G/A

Jefferies Financial Group Inc.

13 Nov 24

4

Travis Alvin Thompson

13 Nov 24

144

Notice of proposed sale of securities

12 Nov 24

4

Kevin Lee

4 Oct 24

4

Michael Charles Ferguson Hannay

4 Oct 24

4

Michael Skynner

4 Oct 24

4

Alistair Milnes

4 Oct 24

4

Nigel Crockett

4 Oct 24